Healthcare -
Biotechnology - NASDAQ - US
$ 0.8696
-0.046 %
$ 47.4 M
Market Cap
10.87
P/E
SPRO - STOCK-BASED COMPENSATION
Stock-based Compensation SPRO - Spero Therapeutics, Inc.
7.93 M
LAST VALUE
-8.29%
2 YEAR CAGR
23.61%
5 YEAR CAGR
0.00%
10 YEAR CAGR